- Home
- PD vs RLAY Comparison
PD vs RLAY Comparison
Compare PD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PD
- RLAY
- Stock Information
- Founded
- PD 2009
- RLAY 2015
- Country
- PD United States
- RLAY United States
- Employees
- PD N/A
- RLAY N/A
- Industry
- PD Computer Software: Prepackaged Software
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PD Technology
- RLAY Health Care
- Exchange
- PD Nasdaq
- RLAY Nasdaq
- Market Cap
- PD 1.5B
- RLAY 803.4M
- IPO Year
- PD 2019
- RLAY 2020
- Fundamental
- Price
- PD $16.06
- RLAY $7.14
- Analyst Decision
- PD Hold
- RLAY Strong Buy
- Analyst Count
- PD 9
- RLAY 8
- Target Price
- PD $18.33
- RLAY $17.25
- AVG Volume (30 Days)
- PD 2.0M
- RLAY 2.0M
- Earning Date
- PD 11-25-2025
- RLAY 11-06-2025
- Dividend Yield
- PD N/A
- RLAY N/A
- EPS Growth
- PD N/A
- RLAY N/A
- EPS
- PD N/A
- RLAY N/A
- Revenue
- PD $483,608,000.00
- RLAY $8,355,000.00
- Revenue This Year
- PD $9.16
- RLAY $27.30
- Revenue Next Year
- PD $6.79
- RLAY $7.43
- P/E Ratio
- PD N/A
- RLAY N/A
- Revenue Growth
- PD 8.20
- RLAY N/A
- 52 Week Low
- PD $13.70
- RLAY $1.78
- 52 Week High
- PD $21.98
- RLAY $7.64
- Technical
- Relative Strength Index (RSI)
- PD 50.47
- RLAY 63.44
- Support Level
- PD $15.58
- RLAY $6.30
- Resistance Level
- PD $16.40
- RLAY $7.64
- Average True Range (ATR)
- PD 0.39
- RLAY 0.44
- MACD
- PD -0.00
- RLAY -0.02
- Stochastic Oscillator
- PD 62.21
- RLAY 72.07
About PD PagerDuty Inc.
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).